Please login to the form below

Not currently logged in
Email:
Password:

atacicept

This page shows the latest atacicept news and features for those working in and with pharma, biotech and healthcare.

Merck's pharma unit faces tougher 2017 as fertility boost recedes

Merck's pharma unit faces tougher 2017 as fertility boost recedes

Meanwhile, Merck suffered a setback in its mid-stage pipeline recently after its systemic lupus erythematosus (SLE) candidate atacicept failed to meet its objectives in a clinical trial, although it did

Latest news

  • Lupus – a 'great imitator'

    Atacicept is unique in that it is being developed solely for the treatment of lupus. ... Lupus nephritis trials have largely been unsuccessful, therefore it is hoped that, with the change in patient population, atacicept will show some efficacy in these

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics